Cite

HARVARD Citation

    Chuaypen, N. et al. (2016). Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with HBeAg‐positive chronic hepatitis B. Liver international. pp. 827-836. [Online]. 
  
Back to record